论文部分内容阅读
尼莫地平(Nimodipine)是一种1,4双氢吡啶类,第二代钙抗剂,亦叫钙通道阻断剂,它能选择性的扩张脑血管无盗血现象,能明显的增加脑血流量,并具有降压而不降低脑血流量,甚至能增加脑血流的作用。我们自1990年试用尼莫地平治疗脑梗塞32例疗效较为满意,报告如下:1 资料与方法1.1 一般资料:患者皆为住院病人,其中男性21例,女性11例,年龄在38～70岁,平均50岁。诊断标准按1978年第二届全国精神科学会议制订的各类脑血管病诊断要点并经CT证实,病程半天～9个月,一周内为最多,占89％。1.2 病情分度:按意识障碍及瘫痪程度分为轻(17例),中(9例),重(5例)。轻度:肌力Ⅳ级,中度:肌力Ⅲ～Ⅲ级,重
Nimodipine is a 1,4-dihydropyridine, second-generation calcium antagonist, also known as calcium channel blockers, it can selectively dilate cerebral blood vessels without stealing phenomenon, can significantly increase the brain Blood flow and blood pressure without lowering cerebral blood flow, and even increase the role of cerebral blood flow. We have tried since 1990, nimodipine treatment of 32 cases of cerebral infarction more satisfactory, the report is as follows: 1 Materials and Methods 1.1 General Information: All patients were hospitalized patients, including 21 males and 11 females, aged 38 to 70 years, Average 50 years old. Diagnostic criteria according to the second session of the National Psychiatric Science Conference in 1978 to develop various types of cerebrovascular disease diagnosis and confirmed by CT, duration of half a day ~ 9 months, up to a week, accounting for 89%. 1.2 Disease Index: According to the degree of disturbance of consciousness and paralysis were divided into light (17 cases), medium (9 cases), severe (5 cases). Mild: muscle strength Ⅳ, moderate: muscle Ⅲ ~ Ⅲ grade, weight